Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Artificial intelligence-detected HER2 strong-positive tumor proportion predicts FISH positivity and treatment response in breast cancer.

PloS one·2026
Same author

Co-transplantation of pancreatic islets with adipose-derived mesenchymal stem cells in vascularized kidney ECM scaffolds to restore type 1 diabetes mellitus.

Bioactive materials·2026
Same author

Celecoxib potentiates ribociclib-induced apoptosis and anti-tumor activity by co-targeting COX-2/NF-κB and PI3K/AKT/mTOR pathways in hormone receptor-positive/HER2-negative breast cancer.

Apoptosis : an international journal on programmed cell death·2026
Same author

Ex vivo endothelialized cECM-enriched core-shell fibrous vascular graft promotes rapid regenerative remodeling in vivo.

Bioactive materials·2026
Same author

Rapid CAR screening and circRNA-driven CAR-NK cells for persistent shed-resistant immunotherapy.

Signal transduction and targeted therapy·2026
Same author

Therapy-induced senescent cancer cells as bidirectional regulators of antitumor immunity and resistance in the tumor microenvironment.

Cell death & disease·2026

相关实验视频

Updated: Sep 14, 2025

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response
06:06

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response

Published on: November 10, 2023

1.5K

免疫性细胞死亡诱导剂的高通量选系统使用基于人工智能的实时图像分析.

Eunseo Kim1, Donghoon Jang2, Minji Kim1

  • 1Department of Biomedical Science, Program in Biomedical Science and Engineering, Graduate school, Inha University, Incheon, 22212, Republic of Korea.

Computers in biology and medicine
|July 23, 2025
PubMed
概括

一个人工智能 (AI) 系统通过分析细胞形态来选免疫细胞死亡 (ICD) 诱导物. 这种基于人工智能的方法可以有效地识别潜在的癌症免疫治疗剂,改善药物发现.

关键词:
细胞检测检测 细胞检测与损伤相关的分子模式.高通量选的高通量选免疫性细胞死亡诱导剂实时图像分析实时图像分析转移学习转移学习深度学习是一种深度学习.

更多相关视频

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.2K
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

2.2K

相关实验视频

Last Updated: Sep 14, 2025

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response
06:06

Author Spotlight: A Streamlined Approach to Studying Cell Death Initiation in Hypersensitive Response

Published on: November 10, 2023

1.5K
Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence
09:11

Automation of the Micronucleus Assay Using Imaging Flow Cytometry and Artificial Intelligence

Published on: January 27, 2023

2.2K
High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds
13:59

High-Content Screening Assay for the Identification of Antibody-Dependent Cellular Cytotoxicity Modifying Compounds

Published on: August 18, 2023

2.2K

科学领域:

  • 免疫学 免疫学 免疫学
  • 生物技术是生物技术.
  • 计算生物学 计算生物学

背景情况:

  • 免疫性细胞死亡 (ICD) 对于将免疫学上"冷"的瘤转化为"热"的瘤至关重要,从而提高癌症免疫疗法的有效性.
  • 由于需要快速大规模评估细胞形态和损伤相关分子模式 (DAMP) 动态,对ICD诱导物的有效查具有挑战性.
  • 先进的图像处理能力对于开发高效的ICD选系统至关重要.

研究的目的:

  • 开发一种基于人工智能 (AI) 的探测器,用于ICD诱导器的高通量选 (HTS).
  • 使用AI识别与ICD相关的典型细胞形态.
  • 为了提高ICD诱导选的效率和准确性.

主要方法:

  • 开发了一种AI探测器,利用光标记器的转移学习和微调差异干扰对比 (DIC) 图像进行微调.
  • 使用模型辅助标签 (MAL) 来提高注释效率并减少手动标签工作.
  • 通过分析细胞死亡类型,DAMP释放和免疫激活来验证AI识别的候选人.

主要成果:

  • 在一个盲测试中,AI系统成功地从八个候选者中识别了三种ICD诱导剂.
  • 基于人工智能的HTS系统只使用实时光学图像高效地选ICD候选者,大大减少了时间和资源.
  • 该系统展示了检测细微形态差异的能力,这些差异通常会被手动分析遗漏.

结论:

  • 开发的基于人工智能的HTS系统提供了一种有效的方法来识别ICD诱导剂.
  • 这种方法有可能加速新型癌症免疫疗法的发现.
  • 人工智能系统对ICD预测,基础研究和药物发现中的更广泛的查应用具有前景.